65 related articles for article (PubMed ID: 19392788)
1. Chronic cerebrospinal vascular insufficiency is not associated with HLA DRB1*1501 status in multiple sclerosis patients.
Weinstock-Guttman B; Zivadinov R; Cutter G; Tamaño-Blanco M; Marr K; Badgett D; Carl E; Elfadil M; Kennedy C; Benedict RH; Ramanathan M
PLoS One; 2011 Feb; 6(2):e16802. PubMed ID: 21340025
[TBL] [Abstract][Full Text] [Related]
2. Interaction between adolescent obesity and HLA risk genes in the etiology of multiple sclerosis.
Hedström AK; Lima Bomfim I; Barcellos L; Gianfrancesco M; Schaefer C; Kockum I; Olsson T; Alfredsson L
Neurology; 2014 Mar; 82(10):865-72. PubMed ID: 24500647
[TBL] [Abstract][Full Text] [Related]
3. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis.
; ; Sawcer S; Hellenthal G; Pirinen M; Spencer CC; Patsopoulos NA; Moutsianas L; Dilthey A; Su Z; Freeman C; Hunt SE; Edkins S; Gray E; Booth DR; Potter SC; Goris A; Band G; Oturai AB; Strange A; Saarela J; Bellenguez C; Fontaine B; Gillman M; Hemmer B; Gwilliam R; Zipp F; Jayakumar A; Martin R; Leslie S; Hawkins S; Giannoulatou E; D'alfonso S; Blackburn H; Martinelli Boneschi F; Liddle J; Harbo HF; Perez ML; Spurkland A; Waller MJ; Mycko MP; Ricketts M; Comabella M; Hammond N; Kockum I; McCann OT; Ban M; Whittaker P; Kemppinen A; Weston P; Hawkins C; Widaa S; Zajicek J; Dronov S; Robertson N; Bumpstead SJ; Barcellos LF; Ravindrarajah R; Abraham R; Alfredsson L; Ardlie K; Aubin C; Baker A; Baker K; Baranzini SE; Bergamaschi L; Bergamaschi R; Bernstein A; Berthele A; Boggild M; Bradfield JP; Brassat D; Broadley SA; Buck D; Butzkueven H; Capra R; Carroll WM; Cavalla P; Celius EG; Cepok S; Chiavacci R; Clerget-Darpoux F; Clysters K; Comi G; Cossburn M; Cournu-Rebeix I; Cox MB; Cozen W; Cree BA; Cross AH; Cusi D; Daly MJ; Davis E; de Bakker PI; Debouverie M; D'hooghe MB; Dixon K; Dobosi R; Dubois B; Ellinghaus D; Elovaara I; Esposito F; Fontenille C; Foote S; Franke A; Galimberti D; Ghezzi A; Glessner J; Gomez R; Gout O; Graham C; Grant SF; Guerini FR; Hakonarson H; Hall P; Hamsten A; Hartung HP; Heard RN; Heath S; Hobart J; Hoshi M; Infante-Duarte C; Ingram G; Ingram W; Islam T; Jagodic M; Kabesch M; Kermode AG; Kilpatrick TJ; Kim C; Klopp N; Koivisto K; Larsson M; Lathrop M; Lechner-Scott JS; Leone MA; Leppä V; Liljedahl U; Bomfim IL; Lincoln RR; Link J; Liu J; Lorentzen AR; Lupoli S; Macciardi F; Mack T; Marriott M; Martinelli V; Mason D; McCauley JL; Mentch F; Mero IL; Mihalova T; Montalban X; Mottershead J; Myhr KM; Naldi P; Ollier W; Page A; Palotie A; Pelletier J; Piccio L; Pickersgill T; Piehl F; Pobywajlo S; Quach HL; Ramsay PP; Reunanen M; Reynolds R; Rioux JD; Rodegher M; Roesner S; Rubio JP; Rückert IM; Salvetti M; Salvi E; Santaniello A; Schaefer CA; Schreiber S; Schulze C; Scott RJ; Sellebjerg F; Selmaj KW; Sexton D; Shen L; Simms-Acuna B; Skidmore S; Sleiman PM; Smestad C; Sørensen PS; Søndergaard HB; Stankovich J; Strange RC; Sulonen AM; Sundqvist E; Syvänen AC; Taddeo F; Taylor B; Blackwell JM; Tienari P; Bramon E; Tourbah A; Brown MA; Tronczynska E; Casas JP; Tubridy N; Corvin A; Vickery J; Jankowski J; Villoslada P; Markus HS; Wang K; Mathew CG; Wason J; Palmer CN; Wichmann HE; Plomin R; Willoughby E; Rautanen A; Winkelmann J; Wittig M; Trembath RC; Yaouanq J; Viswanathan AC; Zhang H; Wood NW; Zuvich R; Deloukas P; Langford C; Duncanson A; Oksenberg JR; Pericak-Vance MA; Haines JL; Olsson T; Hillert J; Ivinson AJ; De Jager PL; Peltonen L; Stewart GJ; Hafler DA; Hauser SL; McVean G; Donnelly P; Compston A
Nature; 2011 Aug; 476(7359):214-9. PubMed ID: 21833088
[TBL] [Abstract][Full Text] [Related]
4. Is multiple sclerosis progression associated with the HLA-DR15 haplotype?
Stürner KH; Siembab I; Schön G; Stellmann JP; Heidari N; Fehse B; Heesen C; Eiermann TH; Martin R; Binder TM
Mult Scler J Exp Transl Clin; 2019; 5(4):2055217319894615. PubMed ID: 31839982
[TBL] [Abstract][Full Text] [Related]
5. Deconstruction of HLA-DRB1*04:01:01 and HLA-DRB1*15:01:01 class II haplotypes using next-generation sequencing in European-Americans with multiple sclerosis.
Creary LE; Mallempati KC; Gangavarapu S; Caillier SJ; Oksenberg JR; Fernández-Viňa MA
Mult Scler; 2019 May; 25(6):772-782. PubMed ID: 29683085
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers in Multiple Sclerosis.
Paul A; Comabella M; Gandhi R
Cold Spring Harb Perspect Med; 2019 Mar; 9(3):. PubMed ID: 29500303
[TBL] [Abstract][Full Text] [Related]
7. HLA-DRB1 the notorious gene in the mosaic of autoimmunity.
Arango MT; Perricone C; Kivity S; Cipriano E; Ceccarelli F; Valesini G; Shoenfeld Y
Immunol Res; 2017 Feb; 65(1):82-98. PubMed ID: 27435705
[TBL] [Abstract][Full Text] [Related]
8. The importance of HLA DRB1 gene allele to clinical features and disability in patients with multiple sclerosis in Lithuania.
Balnyte R; Rastenyte D; Vaitkus A; Mickeviciene D; Skrodeniene E; Vitkauskiene A; Uloziene I
BMC Neurol; 2013 Jul; 13():77. PubMed ID: 23837503
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers in Multiple Sclerosis: An Up-to-Date Overview.
Katsavos S; Anagnostouli M
Mult Scler Int; 2013; 2013():340508. PubMed ID: 23401777
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity in multiple sclerosis: scratching the surface of a complex disease.
Disanto G; Berlanga AJ; Handel AE; Para AE; Burrell AM; Fries A; Handunnetthi L; De Luca GC; Morahan JM
Autoimmune Dis; 2010 Dec; 2011():932351. PubMed ID: 21197462
[TBL] [Abstract][Full Text] [Related]
11. Association between the IL7R T244I polymorphism and multiple sclerosis: a meta-analysis.
Zhang R; Duan L; Jiang Y; Zhang X; Sun P; Li J; Zhang M; Tang G; Wang X; Li X
Mol Biol Rep; 2011 Nov; 38(8):5079-84. PubMed ID: 21161391
[TBL] [Abstract][Full Text] [Related]
12. A polymorphism in the HLA-DPB1 gene is associated with susceptibility to multiple sclerosis.
Field J; Browning SR; Johnson LJ; Danoy P; Varney MD; Tait BD; Gandhi KS; Charlesworth JC; Heard RN; ; Stewart GJ; Kilpatrick TJ; Foote SJ; Bahlo M; Butzkueven H; Wiley J; Booth DR; Taylor BV; Brown MA; Rubio JP; Stankovich J
PLoS One; 2010 Oct; 5(10):e13454. PubMed ID: 21049023
[TBL] [Abstract][Full Text] [Related]
13. Multiple sclerosis susceptibility-associated SNPs do not influence disease severity measures in a cohort of Australian MS patients.
Jensen CJ; Stankovich J; Van der Walt A; Bahlo M; Taylor BV; van der Mei IA; Foote SJ; Kilpatrick TJ; Johnson LJ; Wilkins E; Field J; Danoy P; Brown MA; ; Rubio JP; Butzkueven H
PLoS One; 2010 Apr; 5(4):e10003. PubMed ID: 20368992
[TBL] [Abstract][Full Text] [Related]
14. HLA-DRB1 associations with disease susceptibility and clinical course in Australians with multiple sclerosis.
Stankovich J; Butzkueven H; Marriott M; Chapman C; Tubridy N; Tait BD; Varney MD; Taylor BV; Foote SJ; ; Kilpatrick TJ; Rubio JP
Tissue Antigens; 2009 Jul; 74(1):17-21. PubMed ID: 19392788
[TBL] [Abstract][Full Text] [Related]
15. The role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese Multiple Sclerosis population.
Silva AM; Pereira C; Bettencourt A; Carvalho C; Couto AR; Leite MI; Marta M; Freijo M; Costa PP; Mendonça D; Monteiro L; Armas JB; Martins B
J Neurol Sci; 2007 Jul; 258(1-2):69-74. PubMed ID: 17412364
[TBL] [Abstract][Full Text] [Related]
16. Influence of HLA-DRB1 allele heterogeneity on disease risk and clinical course in a West Australian MS cohort: a high-resolution genotyping study.
Wu JS; James I; Wei Qiu ; Castley A; Christiansen FT; Carroll WM; Mastaglia FL; Kermode AG
Mult Scler; 2010 May; 16(5):526-32. PubMed ID: 20207784
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis.
Barcellos LF; Sawcer S; Ramsay PP; Baranzini SE; Thomson G; Briggs F; Cree BC; Begovich AB; Villoslada P; Montalban X; Uccelli A; Savettieri G; Lincoln RR; DeLoa C; Haines JL; Pericak-Vance MA; Compston A; Hauser SL; Oksenberg JR
Hum Mol Genet; 2006 Sep; 15(18):2813-24. PubMed ID: 16905561
[TBL] [Abstract][Full Text] [Related]
18. HLA-DR15 haplotype and multiple sclerosis: a HuGE review.
Schmidt H; Williamson D; Ashley-Koch A
Am J Epidemiol; 2007 May; 165(10):1097-109. PubMed ID: 17329717
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
